Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp shows a slight decrease today, losing -€0.050 (-0.920%) compared to yesterday.
Chromadex Corp is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
With a target price of 10 € there is a hugely positive potential of 85.19% for Chromadex Corp compared to the current price of 5.4 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -0.920% | 0.000% | -1.802% | 6.863% | -0.909% | 200.773% | 41.192% |
| Intellia Therapeutics Inc | 4.770% | 22.436% | 27.627% | -1.308% | 25.698% | -72.121% | -84.169% |
| Polynovo Ltd | -2.210% | 3.030% | 2.256% | -43.802% | 0.000% | -56.962% | -63.043% |
| Starpharma Holdings Ltd. | -7.350% | 10.270% | 5.699% | 242.857% | 4.082% | -52.045% | -78.029% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat